CYCCP - Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10
Previous close
8.87
0 0%
Share volume: 1,134
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$8.87
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-17.85%
1 Month
-23.71%
3 Months
6.94%
6 Months
-56.70%
1 Year
-41.02%
2 Year
26.05%
Key data
Stock price
$8.87
DAY RANGE
N/A - N/A
52 WEEK RANGE
$5.21 - $22.20
52 WEEK CHANGE
-$0.41
DIVIDEND
$0.15
EX-DIVIDEND DATE
01/19/2024
NEXT EARNINGS DATE
N/A
Company detail
CEO: Spiro Rombotis
Region: US
Website: http://www.cyclacel.com/
Employees: 15
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.cyclacel.com/
Employees: 15
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
cyclacel limited is a pharmaceuticals company located in 46-48 e smithfield, london, united kingdom.
Recent news